Results 221 to 230 of about 49,525 (269)

Perioperative Anaphylaxis: A Systematic Approach to Evaluate High-Risk Drug Allergy. [PDF]

Case Rep Crit Care
Navard-Keck A, Gabryszewski SJ, Robbins ES, Cafone J, Lee J.   +4 more
europepmc   +1 more source

Methadone and Buprenorphine as Medication for Addiction Treatment Diversely Affect Inflammation and Craving Depending on Their Doses. [PDF]

Pharmacy (Basel)
Leventelis C, Veskoukis AS, Rojas Gil AP, Papadopoulos P, Garderi M, Angeli A, Kampitsi A, Tsironi M.   +7 more
europepmc   +1 more source

An analysis of factors influencing dropout in methadone maintenance treatment program in Dehong Prefecture of China based on Cox regression and decision tree modelling. [PDF]

BMC Health Serv Res
Zhou Q, Tang R, Yang Y, Ye R, Gao J, Li L, Xiang L, Duan S, Shan D.   +8 more
europepmc   +1 more source

Pharmacogenetic Evaluation of Hospitalized Patients Requiring Naloxone for Reversal of Acute Opioid Toxicity. [PDF]

Hosp Pharm
Grahl J, Mills M, Singh A, Oxencis C, Mohr A, Mancuso T, Teng BQ, Bajorunaite R, Carver T, Peppard WJ.   +9 more
europepmc   +1 more source

The Relationship Between Methadone and Buprenorphine Enrollment and Overdose Prevention and Treatment Behaviors Among a Community Sample of People Who Use Opioids in Baltimore, Maryland. [PDF]

Int J Environ Res Public Health
Latkin CA, Dayton L, Davey-Rothwell M, Jones A.   +3 more
europepmc   +1 more source

New Synthesis and Pharmacological Evaluation of Enantiomerically Pure (<i>R</i>)- and (<i>S</i>)-Methadone Metabolites as <i>N</i>-Methyl-d-aspartate Receptor Antagonists. [PDF]

J Med Chem
Banzato M, Furlan A, Locatelli P, Sgrignani J, Ongaro A, Dolmella A, De Martin S, Comai S, Cavalli A, Inturrisi C, Bettini E, Manfredi PL, Mattarei A.   +12 more
europepmc   +1 more source

U.S. substance use harm reduction efforts: a review of the current state of policy, policy barriers, and recommendations. [PDF]

Harm Reduct J
Pridgen BE, Bontemps AP, Lloyd AR, Wagner WP, Kay ES, Eaton EF, Cropsey KL.   +6 more
europepmc   +1 more source

Barriers to Universal Availability of Medications for Opioid Use Disorder in US Jails.

JAMA Netw Open
Flanagan Balawajder E, Ducharme L, Taylor BG, Lamuda PA, Kolak M, Friedmann PD, Pollack HA, Schneider JA.   +7 more
europepmc   +1 more source

Methadone and methadone metabolites in postmortem specimens [PDF]

Forensic Science, Medicine, and Pathology, 2008
We have determined drug/metabolite concentrations and ratios of methadone (METH) to two of its metabolites (EDDP, 2-ethylidene-1, 5-dimethyl-3, 3-diphenylpyrrolidine; and EMDP, 2-ethyl-5-methyl-3,3-diphenylpyrroline) in postmortem peripheral blood and liver tissue by liquid chromatography/tandem mass spectrometry.
Ashraf Mozayani, Luis A. Sanchez, Terry J. Danielson   +2 more
openaire   +2 more sources